Corporate Corruption News ArticlesExcerpts of key news articles on corporate corruption
Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.
The latest study to look at the long-term effects of Roundup, a popular weed killer developed by Monsanto in the 1970s, raises questions about the herbicide's possible contributions to poor health in certain communities. The study, published Tuesday in JAMA, tracked people over the age of 50 in southern California from 1993-1996 to 2014-2016, with researchers periodically collecting urine samples during that time. The percentage of people who tested positive for a chemical called glyphosate, which is the active ingredient in the herbicide Roundup, shot up by 500% in that time period. The levels of glyphosate also spiked by 1208% during that time. One trial from the UK, in which rats were fed low levels of glyphosate throughout their lives, found that the chemical contributed to a higher risk of nonalcoholic fatty liver disease, a condition in which fat accumulates in the liver and contributes to inflammation and scarring of the tissue. [Researcher Paul] Mills says that the levels of glyphosate documented in the people in his study were 100-fold greater than those in the rats. While Roundup was developed to eliminate most weeds from genetically modified crops – and thus reduce the amount of pesticides sprayed on them – recent studies have found that many weeds are now resistant to Roundup. That means growers are using more Roundup, which could only exacerbate potential negative health effects on people who consume those products.
Note: Bayer recently agreed to a $10 billion settlement over claims that its glyphosate-containing product RoundUp causes cancer. Meanwhile, Mexico is banning glyphosate and GMO corn. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and GMOs from reliable major media sources.
A mini-runway, lined with stiletto heels, glistens in bright fluorescent lighting. Shoes of various types sit neatly in individual glass shelves. It was a private launch party of a new luxury brand of shoes called Palessi, designed by Italian designer Bruno Palessi. “I would pay $400, $500.’” a woman said as she tried on a pair of bright-gold sneakers. The woman was not actually buying a Palessi because there’s no such brand, and there’s no Bruno Palessi. There is, however, Payless ShoeSource, a discount shoe retailer hoping to shake things up through an ... advertising prank to attract new customers and change the perception that the company sells cheap, unfashionable shoes. The prank also points to a reality about the human mind: Consumers are not capable of discerning the quality and value of the things they buy, said Philip Graves, a consumer behavior consultant. Slap a fancy-sounding European label on $30 shoes, and you have an illusion of status that people will pay an exorbitant amount of money for. On the day of the launch ... after attendees purchased overpriced shoes ― some for $200, $400 and $600 ― they were taken toward the backroom, where the prank was revealed. “You’ve got to be kidding me,” said [one attendee], her eyes wide as she stared down at the overpriced shoes in her hands. “Consumers have been paying hugely inflated prices,” [said Graves]. “Some of the pleasures that we get from things that we buy come from the money we spent on them.”
Note: While this marketing prank demonstrated the public's willingness to ignore product quality in evaluating the cost of purchases, a much more serious study recently found that the average CEO-to-worker pay ratio has now reached 339 to 1 across US companies.
For 23 years, Larry Collins worked in a [toll] booth. But one day in mid-March, as confirmed cases of the coronavirus were skyrocketing, Collins’ supervisor called and told him not to come into work the next day. Collins’ job was disappearing, as were the jobs of around 185 other toll collectors at bridges in Northern California, all to be replaced by technology. The drive to replace humans with machinery is accelerating as companies struggle to avoid workplace infections of COVID-19 and to keep operating costs low. The U.S. shed around 40 million jobs at the peak of the pandemic. Some will never return. One group of economists estimates that 42% of the jobs lost are gone forever. This replacement of humans with machines may pick up more speed in coming months as companies move from survival mode to figuring out how to operate while the pandemic drags on. Robots could replace as many as 2 million more workers in manufacturing alone by 2025. “Look at the business model of Google, Facebook, Netflix. They’re not in the business of creating new tasks for humans,” says Daron Acemoglu, an MIT economist. The U.S. government incentivizes companies to automate, he says, by giving tax breaks for buying machinery and software. A business that pays a worker $100 pays $30 in taxes, but a business that spends $100 on equipment pays about $3 in taxes, he notes. The 2017 Tax Cuts and Jobs Act lowered taxes on purchases so much that “you can actually make money buying equipment,” Acemoglu says.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus from reliable major media sources.
Jada Renee Louis of Newport News, Virginia, died on 22 June 2019 about a week after requiring emergency hospital care for diabetic ketoacidosis, a serious complication caused by a lack of insulin, and a foot ulcer. She was 24. A type 1 diabetic, Louis, who did not have health insurance coverage, couldn’t afford the cost of her insulin doses and pay her rent. She chose to skip doses in order to pay her rent. Today a vial of insulin – which will last 28 days once opened – costs about $300 in the US. “People are literally dying over $300 like my sister did. People shouldn’t have to choose between medications or shelter. That’s the most outrageous decision for somebody to have to make, yet people are doing it daily,” Jazmine Baldwin, Louis’s sister, [said]. Price gouging of insulin and other barriers to accessing it are symptomatic of America’s broken healthcare system, diabetes advocates argue, and the resulting deaths and struggles of those with diabetes demonstrate the need for systemic reforms. Between 2012 to 2016, the average cost of insulin in the United States nearly doubled to $5,705 per year for individuals with type 1 diabetes. Production costs for a vial of insulin are estimated to cost around $5 while pharmaceutical companies charge as high as $540 per vial and Americans are dying as a result of being unable to afford it in addition to the expensive costs of medical care, and supplies such as syringes and glucose monitors. Some 1.25 million Americans are currently diagnosed with type 1 diabetes.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
Synthetic chemicals called phthalates, found in hundreds of consumer products such as food storage containers, shampoo, makeup, perfume and children's toys, may contribute to some 91,000 to 107,000 premature deaths a year among people ages 55 to 64 in the United States, a new study found. People with the highest levels of phthalates had a greater risk of death from any cause, especially cardiovascular mortality, according to the study published Tuesday in the peer-reviewed journal Environmental Pollution. Phthalates are known to interfere with the body's mechanism for hormone production, known as the endocrine system, and they are "linked with developmental, reproductive, brain, immune, and other problems," according to the National Institute of Environmental Health Sciences. Even small hormonal disruptions can cause "significant developmental and biological effects," the NIEHS states. Prior research has connected phthalates with reproductive problems, such as genital malformations and undescended testes in baby boys and lower sperm counts and testosterone levels in adult males. Often called "everywhere chemicals" because they are so common, phthalates are added to consumer products such as PVC plumbing, vinyl flooring, rain- and stain-resistant products, medical tubing, garden hoses, and some children's toys. Other common exposures come from the use of phthalates in food packaging, detergents, clothing, furniture and automotive plastics.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
The chairman of a House subcommittee is demanding that executives of Exxon Mobil Corp., Shell, Chevron and other major oil and gas companies testify before Congress about the industry's decades-long effort to wage disinformation campaigns around climate change. Representative Ro Khanna, Democrat of California, said Friday he was prepared to use subpoena power to compel the companies to appear before lawmakers if they don't do so voluntarily. The move comes a day after a secretive video recording was made public in which a senior Exxon lobbyist said the energy giant had fought climate science through "shadow groups" and had targeted influential senators in an effort to weaken President Biden's climate agenda. "The video was appalling," Mr. Khanna said in an interview on Friday. He called it the latest evidence of the fossil fuel industry's efforts to "engage in climate denialism and to manipulate public opinion and to exert undue influence in shaping policy in Congress." Mr. Khanna said the House Oversight and Reform Subcommittee on the Environment, which he chairs, will issue letters next week to top executives at Exxon Mobil, Shell, Chevron and other oil and gas companies and trade groups demanding documents and testimony. One major target of the panel's inquiry are dark money groups that have been funded by fossil fuel companies to disseminate falsehoods about climate science and policy solutions. The hearing is expected to be held in the fall.
Note: Learn more in this Washington Post article. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and climate change from reliable major media sources.
The wealthiest Americans – including Warren Buffett, Elon Musk and Jeff Bezos – paid little in federal income taxes at times in recent years despite soaring fortunes, according to Internal Revenue Service data obtained by ProPublica. The information published Tuesday shows how billionaires are able to legally reduce their tax burden, highlighting how the American tax system can hit ordinary wage earners harder than the richest people in the country. That's often because the richest Americans tend to have their wealth tied up in stocks and real estate, allowing them to avoid taxes on unrealized profits. The U.S. tax system focuses on income, not what is known as unrealized gains from unsold stocks, real estate or other assets. The records ... purport to show Buffett, head of Berkshire Hathaway, as having paid $23.7 million in federal income taxes on total income of $125 million from 2014 to 2018, which would indicate a personal income tax rate of 19 percent. ProPublica estimated that Buffett saw his wealth soar by $24.3 billion during that period and so his "true tax rate" was 0.10 percent. Musk, chief executive of Tesla, paid $455 million on $1.52 billion in income during the same period, when his wealth grew by $13.9 billion, accounting for a "true tax rate" of 3.27 percent. Bezos, chief executive of Amazon and the owner of The Washington Post, paid $973 million in taxes on $4.22 billion in income, as his wealth soared by $99 billion, resulting in a 0.98 percent "true tax rate."
Note: Learn about important facts this article leaves out in this excellent piece. For more along these lines, see concise summaries of deeply revealing news articles on income inequality from reliable major media sources.
Covid-19 vaccines have created at least nine new billionaires after shares in companies producing the shots soared. Topping the list of new billionaires are Moderna CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer. Both CEOs are now worth around $4 billion, according to an analysis by the People's Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International. Senior executives from China's CanSino Biologics and early investors in Moderna have also become billionaires on paper as shares skyrocketed. Moderna's share price has gained more than 700% since February 2020, while BioNTech has surged 600%. CanSino Biologics' stock is up about 440% over the same period. The company's single-dose Covid-19 vaccine was approved for use in China in February. Activists said the wealth generation highlighted the stark inequality that has resulted from the pandemic. The nine new billionaires are worth a combined $19.3 billion, enough to fully vaccinate some 780 million people in low-income countries. "These billionaires are the human face of the huge profits many pharmaceutical corporations are making from the monopoly they hold on these vaccines," Anne Marriott, Oxfam's health policy manager, said. "These vaccines were funded by public money and should be first and foremost a global public good, not a private profit opportunity," she added.
Note: You would hope that with all the suffering going on in our world, big Pharma wouldn't gouge and make huge profits on their vaccines. Sadly, this is far from the truth. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.
The pharmaceutical industry is pouring resources into the growing political fight over generic coronavirus vaccines. Over 100 lobbyists have been mobilized to contact lawmakers and members of the Biden administration, urging them to oppose a proposed temporary waiver on intellectual property rights by the World Trade Organization that would allow generic vaccines to be produced globally. Pharmaceutical lobbyists working against the proposal include Mike McKay, a key fundraiser for House Democrats, now working on retainer for Pfizer, as well as several former staff members to the U.S. Office of Trade Representative, which oversees negotiations with the WTO. Several trade groups funded by pharmaceutical firms have also focused closely on defeating the generic proposal, new disclosures show. The U.S. Chamber of Commerce, the Business Roundtable, and the International Intellectual Property Alliance, which all receive drug company money, have dispatched dozens of lobbyists to oppose the initiative. The push has been followed by a number of influential voices taking the side of the drug lobby. Last week, Sen. Thom Tillis, R-N.C., released a letter demanding that the administration "oppose any and all efforts aimed at waiving intellectual property rights." Currently, only 1 percent of coronavirus vaccines are going to low-income countries, and projections show much of the world's population may not be vaccinated until 2023 or 2024.
Note: Has it ever been more clear that big Pharma places profits above health, even when it might cause huge numbers of people to die? For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and coronavirus vaccines from reliable major media sources.
A congressional report found many of the products made by the country's largest commercial baby food manufacturers contain significant levels of toxic heavy metals, including arsenic, lead, cadmium and mercury, which can endanger infant neurological development. The report ... from the House Oversight Committee's subcommittee on economic and consumer policy found heavy metals in rice cereals, sweet potato puree, juices and sweet snack puffs made by some of the most trusted names in baby food. Gerber, Beech-Nut, HappyBABY (made by Nurture) and Earth's Best Organic baby foods (made by Hain Celestial Group) complied with the committee's request to submit internal testing documents. Campbell Soup, which sells Plum Organics baby foods, Walmart (its private brand is Parent's Choice) and Sprout Foods declined to cooperate. Although there are no maximum arsenic levels established for baby food ... the FDA has set the maximum allowable levels in bottled water at 10 ppb of inorganic arsenic. Hain ... used many ingredients in its baby foods with as much as 309 ppb of arsenic. Lead levels in baby foods should not exceed 1 ppb. Beech-Nut used ingredients containing as much as 886.9 parts per billion of lead. In addition, Gerber used carrots containing as much as 87 ppb of cadmium and Nurture sold baby foods with as much as 10 ppb of mercury. And even when baby foods tested over companies' internal limits for these heavy metals, they were sold anyway.
Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
The chairman and CEO of Pfizer, Albert Bourla, sold $5.6 million worth of stock in the pharmaceutical company on Monday. The sale took place on the same day Pfizer announced that its experimental coronavirus vaccine candidate was found to be more than 90% effective. Bourla's sale of Pfizer stock was part of a trading plan set months in advance. Known as 10b5-1 plans, they essentially put stock trades on autopilot. Executives are supposed to adopt these plans only when they are not in possession of inside information that can affect a company's stock price. On Aug. 19, Bourla implemented his stock-trading plan. The next day, Aug. 20, Pfizer issued a press release ... confirming that Pfizer and its German partner, BioNTech, were "on track to seek regulatory review" for its vaccine candidate. Daniel Taylor, an expert in insider trading ... told NPR that the close timing between the adoption of Bourla's stock plan and the press release looked "very suspicious." "It's wholly inappropriate for executives at pharmaceutical companies to be implementing or modifying 10b5-1 plans the business day before they announce data or results from drug trials," Taylor said. The stock sales by Pfizer's CEO brought to mind similar concerns with another coronavirus vaccine-maker, Moderna. Multiple executives at Moderna adopted or modified their stock-trading plans just before key announcements about the company's vaccine. Those executives have sold tens of millions of dollars in Moderna stock.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.
Moderna CEO StÄ‚©phane Bancel more than tripled the number of his company shares to be sold through an executive stock plan that was changed just days after the biotech in May announced positive early results for its coronavirus vaccine. Moderna's shares spiked on the May news, rising 30% in just one day. After seeking the executive stock plan change in May, Bancel sold more than 72,000 Moderna shares in the first 16 days of July, generating nearly $4.8 million for the executive. That was more than triple the 22,000 shares he had previously scheduled to sell during the same period through the company's executive trading plan. Another top Moderna executive, President Stephen Hoge, also had his pre-programmed executive trading plan reset around the same time. The change allowed him to sell $1.9 million worth of Moderna stock in the first two weeks of July. The executives' ... sales were made through what are known as 10b5-1 stock plans. These arrangements must be set up or amended at least 30 days before any transactions are executed; they are commonly used at publicly traded companies to help shield executives from potential claims of insider trading. The fact that the plans were changed during the pandemic as news was emerging about the company's closely watched coronavirus vaccine raises new questions about how Moderna executives have pocketed millions of dollars in recent months.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.
Bayer will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its Roundup herbicide causes cancer, the company announced. Monsanto, bought by Bayer in 2018, lost a lawsuit that same year brought by a school groundskeeper who claimed its weedkiller had caused his non-Hodgkin's lymphoma. Since then, thousands of U.S. lawsuits have been filed against the company. The settlement, however, does not contain an admission of wrongdoing or liability. Bayer will pay $8.8 billion to $9.6 billion to settle existing lawsuits and then another $1.25 billion that will cover any potential litigation in the future. Lawsuits allege that Monsanto ignored warnings that its herbicide contained potentially cancer causing chemicals, then concealed the threat to consumers. A jury awarded California groundskeeper Dewayne Johnson nearly $290 million in damages in August 2018 after they found Monsanto failed to warn Johnson and other consumers about the risks posed by its weed-killing products. A judge upheld the decision upon appeal, but lowered the damages to $78 million due to what she considered an overreach in punitive damages decided by the jury. And last year, a California jury awarded a husband and wife more than $2 billion in damages in a suit that claimed Roundup caused their illness. German pharmaceuticals and chemical giant Bayer bought Monsanto in 2018 just months before Johnson won his suit against the company. Bayer eliminated the Monsanto name, but maintained the brands.
Note: The negative health impacts of Roundup are well known. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
The COVID-19 pandemic is far from a great equalizer. In the same month that 22 million Americans lost their jobs, the American billionaire class's total wealth increased about 10%–or $282 billion more than it was at the beginning of March. They now have a combined net worth of $3.229 trillion. The initial stock market crash may have dented some net worths at first–for instance, that of Jeff Bezos, which dropped down to a mere $105 billion on March 12. But his riches have rebounded: As of April 15, his net worth has increased by $25 billion. These "pandemic profiteers," as a new report from the Institute for Policy Studies, a progressive think tank, calls them, is just one piece of the wealth inequality puzzle in America. In the background is the fact that since 1980, the taxes paid by billionaires, measured as a percentage of their wealth, dropped 79%. "We're reading about benevolent billionaires sharing .0001% of their wealth with their fellow humans in this crisis, but in fact they've been rigging the tax rules to reduce their taxes for decades–money that could have been spent building a better public health infrastructure," says Chuck Collins [of] the Institute for Policy Studies and coauthor of the new report, titled "Billionaire Bonanza 2020: Wealth Windfalls, Tumbling Taxes, and Pandemic Profiteers." Another key finding of the report is that after the 2008 financial crisis, it took less than 30 months for billionaire wealth to return to its pre-meltdown levels. That wealth then quickly exceeded pre-2008 levels. But as of 2019, the middle class in America has not even yet recovered to the level of its 2007 net worth.
Note: This New York Post article shows how 43,000 millionaires in the U.S. will receive a "stimulus" gift averaging $1.6 million each. At the same time, this Reuters article claims that the coronavirus lockdown could plunge half a billion worldwide into poverty. And this BBC article warns of potential massive famines. So who is this lockdown really serving? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Erik Prince, the security contractor with close ties to the Trump administration, has in recent years helped recruit former American and British spies for secretive intelligence-gathering operations that included infiltrating Democratic congressional campaigns, labor organizations and other groups considered hostile to the Trump agenda. One of the former spies, an ex-MI6 officer named Richard Seddon, helped run a 2017 operation to copy files and record conversations in a Michigan office of ... one of the largest teachers’ unions in the nation. The next year, the same undercover operative infiltrated the congressional campaign of Abigail Spanberger, then a former C.I.A. officer who went on to win an important House seat in Virginia as a Democrat. Both operations were run by Project Veritas, a conservative group that has gained attention using hidden cameras and microphones for sting operations. Mr. Prince, the former head of Blackwater Worldwide ... appears to have become interested in using former spies to train Project Veritas operatives in espionage tactics sometime during the 2016 presidential campaign. In 2017, he met with White House and Pentagon officials to pitch a plan to privatize the Afghan war. Mr. Prince invited Project Veritas operatives ... to his family’s Wyoming ranch for training in 2017. [They] shared social media photos of taking target practice with guns at the ranch, including one post ... saying that with the training, Project Veritas will be “the next great intelligence agency.”
Note: Mr. Prince's Blackwater operation got caught systematically defrauding the government. Then Blackwater changed its name to Academi and made over $300 million off the Afghan drug trade. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Joi Ito, the director of the Media Lab at MIT, resigned Saturday and the university is calling for an independent investigation following explosive allegations that he and at least one other person at the lab made efforts to make sure Jeffrey Epstein's name was not associated with donations he made or helped solicit. Internal communications and documents obtained by CNN - first reported by the New Yorker - show Epstein was integral to incoming donations from major donors, including $2 million from Bill Gates and at least $5 million from Leon Black, the founder of private equity firm Apollo Global Management. Internal email exchanges show Ito was in direct contact with Epstein about the late financier's donations, which documents show at one point were earmarked for a research scientist. As discussions continued about the funding for the researcher, the Director of Development and Strategy, Peter Cohen, sent an email to an undisclosed recipient, saying "Jeffrey money, needs to be anonymous." Internal communications dating back to 2014 include several references to Epstein being allowed to make small donations anonymously. The communications show that Epstein helped as an intermediary on high-dollar proposals. In October of 2014 Ito sent an email stating, "This is a $2M gift from Bill Gates directed by Jeffrey Epstein." His director of Development and Strategy - Cohen - responds "Great! For gift recording purposes, we will not be mentioning Jeffreys name as the impetus for this gift."
Note: For more along these lines, see concise summaries of deeply revealing news articles on Jeffrey Epstein from reliable major media sources.
The origin, evolution and astonishing scale of America’s catastrophic opioid epidemic just got a lot clearer. The drug industry - the pill manufacturers, wholesalers and retailers - found it profitable to flood some of the most vulnerable communities in America with billions of painkillers. They continued to move their product, and the medical community and government agencies failed to take effective action, even when it became apparent that these pills were fueling addiction and overdoses and were getting diverted to the streets. This has been broadly known for years, but this past week, the more precise details became public for the first time. The revelatory data comes from the Drug Enforcement Administration and its Automation of Reports and Consolidated Orders System (ARCOS). “This really shows a relationship between the manufacturers and the distributors: They were all in it together,” said Jim Geldhof, a retired DEA employee. “We’re seeing a lot of internal stuff that basically confirms ... that it was all about greed, and all about money.” The data shows a trend in pill distribution that, according to the lawsuit plaintiffs, can’t be passed off as reasonable therapeutic medical treatment. The industry shipped 76 billion oxycodone and hydrocodone pills across the country from 2006 through 2012, the period covered by the ARCOS data released this past week. These pills didn’t flow in a steady stream but were more like a flash flood, spiking from 8.4 billion in 2006 to 12.6 billion in 2012.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease by 64 percent. The results were from an analysis of hundreds of thousands of insurance claims. Verifying that the drug would actually have that effect in people would require a costly clinical trial - and after several years of internal discussion, Pfizer opted against further investigation and chose not to make the data public, the company confirmed. Researchers in the company’s division of inflammation and immunology urged Pfizer to conduct a clinical trial on thousands of patients, which they estimated would cost $80 million ... according to an internal company document obtained by The Washington Post. Pfizer’s deliberations, which previously have not been disclosed, offer a rare window into the frustrating search for Alzheimer’s treatments inside one of the world’s largest drug companies. Pfizer did share the data privately with at least one prominent scientist, but outside researchers contacted by The Post believe Pfizer also should at least have published its data, making the findings broadly available to researchers. “Of course they should. Why not?” said Rudolph E. Tanzi, a leading Alzheimer’s researcher and professor at Harvard Medical School. “It would benefit the scientific community to have that data out there,” said Keenan Walker, an assistant professor of medicine at Johns Hopkins.
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Purdue Pharma, the drug manufacturer that kickstarted the US opioid epidemic, corruptly influenced the World Health Organization in order to boost painkiller sales across the globe, according to a report by members of Congress. An investigation by Katherine Clark and Hal Rogers, who represent districts in Massachusetts and Kentucky hard hit by the US opioid epidemic, accuses Purdue of replicating its false marketing claims about the safety and effectiveness of opioids to change WHO prescribing guidelines in an attempt to expand foreign markets for its drugs. “The web of influence we uncovered paints a picture of a public health organization that has been corrupted by the opioid industry,” said Clark. “The WHO appears to be lending the opioid industry its voice and credibility, and as a result, a trusted public health organization is trafficking dangerous misinformation that could lead to a global opioid epidemic.” The report ... accuses Purdue of using pharma-funded organizations and specialists to influence the writing of WHO policy to encourage much wider prescribing of addictive high-strength opioids across the globe. It said that, as a result, “WHO guidelines are serving as marketing materials for Purdue”. [The] report alleges two WHO guidelines ... “contain dangerously misleading and, in some instances, outright false claims about the safety and efficacy of prescription opioids”. “Alarmingly, these guidelines mirror Purdue’s marketing strategies to increase prescriptions and expand sales,” the report found.
Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Justin Rosenstein had tweaked his laptop’s operating system to block Reddit, banned himself from Snapchat, which he compares to heroin, and imposed limits on his use of Facebook. He was particularly aware of the allure of Facebook “likes”, which he describes as “bright dings of pseudo-pleasure” that can be as hollow as they are seductive. And Rosenstein should know: he was the Facebook engineer who created the “like” button. There is growing concern that as well as addicting users, technology is contributing toward so-called “continuous partial attention”, severely limiting people’s ability to focus, and possibly lowering IQ. One recent study showed that the mere presence of smartphones damages cognitive capacity – even when the device is turned off. But those concerns are trivial compared with the devastating impact upon the political system that some of Rosenstein’s peers believe can be attributed to the rise of social media and the attention-based market that drives it. Drawing a straight line between addiction to social media and political earthquakes like Brexit and the rise of Donald Trump, they contend that digital forces have completely upended the political system and, left unchecked, could even render democracy as we know it obsolete. It is revealing that many of these younger technologists are weaning themselves off their own products, sending their children to elite Silicon Valley schools where iPhones, iPads and even laptops are banned.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
